Lucintel Newsletter

Business News by Lucintel

Bookmark and Share

Monday, December 13, 2021

Lucintel Forecasts Exosome Market to Grow at a CAGR of 23%-25%

According to the recent study the exosome market is projected to grow at a CAGR of 23%-25% from 2020 to 2025. Growth in this market is primarily driven by increasing funding for life sciences research, the high global prevalence of cancer, and the increasing interest in exosome based procedures.

Browse XX figures / charts and XX tables in this 150-page report to understand trends, opportunities and forecast in exosome market by product & service (kits and reagents, instruments, and services), application (cancer applications (lung cancer, breast cancer, prostate cancer, colorectal cancer, and other cancers) and non-cancer applications), end user (academic & research institutes, pharmaceutical & biotechnology companies, and hospitals & clinical testing laboratories), workflow (isolation methods (ultracentrifugation, immunocapture on beads, precipitation, and filtration) and downstream analysis (cell surface marker analysis using flow cytometry, protein analysis using blotting & ELISA, RNA analysis with NGS & PCR, proteomic analysis using mass spectrometry, and others), biomolecule type (non-coding RNAs, mRNA, proteins/peptides, DNA fragments, and lipids), and region (North America, Europe, Asia Pacific, and Rest of the World).

Download sample report and view detailed Table of Content by clicking on below link https://www.lucintel.com/exosome-market.aspx

“Kits and reagents market is expected to remain the largest segment during the forecast period.”       

Based on product and service, the exosome market is segmented into kits and reagents, instruments, and services. Lucintel forecasts that the kits and reagents market is expected to remain the largest segment during the forecast period due to the increasing demand for liquid biopsy tests, increasing basic research and commercial applications of exosome, and the need for reliable and specific diagnostic assays.  

“Within the exosome market, the academic & research institutes segment is expected to remain the largest end user.”  

Based on end user, the academic & research institutes segment is expected to witness the largest segment over the forecast period due to the growing use of exosome in cancer and stem cell research and increasing number of cancer & stem cell research projects across the globe.

“North America will dominate the exosome market in near future.”

North America is expected to be the highest growth over the forecast period over the forecast period due to availability of government funding for life sciences research, favorable regulatory environment, increasing focus on exosome in research and diagnostics, and the presence of high-quality infrastructure for clinical and laboratory research.

Download Brochure of this report by clicking on https://www.lucintel.com/exosome-market.aspx

Major players of exosome market are adopting various growth strategies like new product launches, expansions, merger and acquisitions, partnerships, agreements, and collaborations to expand their presence in this market. Thermo Fisher Scientific, QIAGEN, Bio-Techne, System Biosciences, NX Pharmagen, Miltenyi Biotec, AMS Biotechnology, NanoSomiX, Lonza, and Norgen Biotek are among the major exosome providers.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/exosome-market.aspx or helpdesk@lucintel.com

About Lucintel

At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times. For further information, visit www.lucintel.com

Contact:
Brandon Fitzgerald
Lucintel
Dallas, Texas, USA
Email:
brandon.fitzgerald@lucintel.com
Tel. 972.636.5056
Cell: 303.775.0751


Related reports

Surgical Instrument Tracking System Market:

For more details click here https://www.lucintel.com/surgical-instrument-tracking-system-market.aspx

 

Metabolomics Market:

For more details click here https://www.lucintel.com/metabolomics-market.aspx

 

Industrial Microbiology Market:

For more details click here https://www.lucintel.com/industrial-microbiology-market.aspx

 

Surgical Microscope Market:

For more details click here https://www.lucintel.com/surgical-microscope-market.aspx

 

Tumor Ablation Market:

For more details click here https://www.lucintel.com/tumor-ablation-market.aspx

 

Vitamin D Market:

For more details click here https://www.lucintel.com/vitamin-d-market.aspx

 

Urology Device Market:

For more details click here https://www.lucintel.com/urology-device-market.aspx

 

Halal Ingredient Market:

For more details click here https://www.lucintel.com/halal-ingredient-market.aspx

 

Gene Expression Market:

For more details click here https://www.lucintel.com/gene-expression-market.aspx

 

GMO Testing Market:

For more details click here https://www.lucintel.com/gmo-testing-market.aspx

No comments:

Post a Comment